Oncology In the Department of Medicine

Current Fellows' Research & Clinical Interests

(Preceptor and Preceptor’s Department or Division)

Oyebimpe Adesina, MD
Clinical fellow; will begin research in January 2014

Anosheh Afghahi, MD
Clinical fellow; will begin research in January 2014

Gregory Behbehani, MD, PhD (Garry Nolan, Microbiology and Immunology)
Proteomic analysis of signaling pathways in leukemic blasts

Steven Chan, MD, PhD (Ravindra Majeti, Hematology)
Discovery of Synthetic Lethal Interactions with Isocitrate Dehydrogenase (IDH) Mutations in Acute Myeloid Leukemia

Daniel Corey, MD
Clinical fellow; will begin research in July 2013

Monique de Bruin, MD, MPH (Allison Kurian, Oncology)
Clinical research in breast and ovarian cancer

Shira Dinner, MD (Michaela Liedtke, Hematology)
Pilot study of bortezomib, lenalidomide and dexamethasone in untreated and treated immunoglobulin light chain (AL) primary systemic amyloidosis

Tamara Dunn, MD (Michaela Liedtke, Hematology)
A phase I study of bortezomib in combination with pralatrexate in relapsed/refractory multiple myeloma

Maryliza El-Masry, MD
Clinical fellow; will begin research in January 2014

Jacqueline Suen Garcia, MD
Clinical fellow; will begin research in January 2013

Wan-Jen Hong, MD (Ravindra Majeti, Hematology)
Characterization of hematopoeitic stem cells in myeloproliferative neoplasms

Robert Wenchen Hsieh, MD, PhD
Clinical fellow; will begin research in March 2013

Brian Jonas, MD, PhD (Ravindra Majeti, Hematology)
Identification and characterization of leukemia stem cells in a mouse model of therapy-related acute myelogenous leukemia (AML)

Michael Khodadoust, MD, PhD
Clinical fellow; will begin research in January 2014

David Matthew Kurtz, MD
Clinical fellow; will begin research in January 2013

Anthony Lam, MD, MHS (H. Wakelee & S. Srinivas, Oncology; S. Schrier, Hematology)
Epidemiologic research in thoracic and urologic malignancies; Epidemiology of elderly anemia; Medtech innovations in hematology/oncology.

Aaron Logan, MD, PhD (Judy Shizuru, BMT)
Antibody-based conditioning for allo-transplant

James (Scott) McClellan, MD, PhD (Ravi Majeti, Hematology)
Investigating new therapeutic strategies for acute lymphoblastic leukemia

Everett Meyer, MD, PhD (Robert Negrin, BMT)
Study alloreactivity in bone marrow transplantation, specifically T cell dynamics in graft-versus-host disease in mouse models and human patients.

Siddhartha Mitra, MD, PhD
Clinical fellow; will begin research in January 2013

Rupa Narayan, MD
Clinical fellow; will begin research in January 2013

Sujata Narayanan, MD
Clinical fellow; will begin research in July 2013

David M. Nguyen, MD
Clinical fellow; will begin research in January 2014

Huong Thien (Marie) Nguyen, MD (Jason Gotlib, Hematology)
Evaluation of novel targeted therapies for patients with MPNs

Kim-Son Hoa Nguyen, MD, MPA
Clinical fellow; will begin research in January 2013

Sukhmani Kaur Padda, MD
Clinical fellow; will begin research in January 2013

Manali Patel, MD (Beverly Mitchell, Oncology)
Clinical trials in acute leukemia

Mary-Elizabeth Muchmore Percival, MD
Clinical fellow; will begin research in January 2013

Elie Richa, MD
Clinical fellow; will begin research in January 2014

Jonathan Riess, MD (Heather Wakelee, Oncology)
Clinical and translational research in thoracic malignancies

Gabriel Rivera, MD
Clinical fellow; will begin research in January 2014

Jeffrey Russell, MD, PhD (Martin Brown, Radiation Oncology)
Radiation-induced vasculogenesis and the role of endothelial precursor cells as mediators of radiation and chemotherapy resistance

Somasundaram Subramaniam, MD (James Ford, Oncology)
Clinical GI oncology research

Alexander Ungewickell, MD, PhD (Paul Khavari, Dermatology)
Cutaneous T-cell lymphomas

Gregory Vidal, MD, PhD (Mark Pegram, Oncology)
Developmental therapeutics and early phase (1 and 11) clinical research project

Victor Villalobos, MD, PhD (Branimir Sikic, Oncology)
XL184 non randomized extension in ovarian cancer. FP1039 a FGF ligand trap in endometroid cancers.

 

Instructors' Research & Clinical Interests

Alice Fan, MD (Dean Felsher, Oncology)
Translational studies to validate the activity of targeted therapies using novel nanoscale technologies.  Applying nanoscale proteomic analysis to clinical study of atorvastatin for lymphoma.

Lincoln Nadauld, MD, PhD (Calvin Kuo, Hematology)
Mouse models for gastric cancer

Shaveta Vinayak, MD (James Ford and Allison Kurian, Oncology)
Translational research in breast cancer

Yu Wong, MD, PhD (Mark Davis, Microbiology and Immunology)
Design of novel approach to measure T cell repertoire. Translational research in breast cancer

 

Stanford Medicine Resources:

Footer Links: